共 50 条
- [41] Sustained virologic response (SVR) to retreatment with IFN alfacon 1 plus ribavirin in HCV/HIV coinfected patients who had failed 12 weeks of PEG IFN alpha 2 plus ribavirin therapy.HEPATOLOGY, 2005, 42 (04) : 698A - 698ALeevy, CChalmers, CBlatt, LM
- [42] HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patientsANTIVIRAL THERAPY, 2017, 22 (05) : 431 - 441Gozlan, YaelBen-Ari, ZivMoscona, RoyShirazi, RachelRakovsky, AviyaKabat, ArijVeizman, EllaBerdichevski, TaniaWeiss, PeretzCohen-Ezra, OranitLurie, YoavGafanovich, InnaBraun, MariusCohen-Naftaly, MichalShlomai, AmirShibolet, OrenZigmond, EhudZuckerman, EliCarmiel-Haggai, MichalNimer, AssyHazzan, RawiMaor, YaakovKitay-Cohen, YonaShemer-Avni, YonatKra-Oz, ZipiSchreiber, LicitaPeleg, OferSierra, SaletaHarrigan, P. RichardMendelson, EllaMor, Orna
- [43] Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4HEPATITIS MONTHLY, 2013, 13 (11)Domagalski, KrzysztofPawlowska, MagorzataTretyn, AndrzejHalota, WaldemarTyczyno, MagorzataKozielewicz, DorotaDybowska, Dorota
- [44] Projecting the Long-Term Clinical Impact of Boceprevir in Patients With Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment With Peginterferon/RibavirinGASTROENTEROLOGY, 2011, 140 (05) : S947 - S947Chhatwal, JagpreetFerrante, Shannon A.Dasbach, Erik J.El Khoury, AntoineBurroughs, MargaretBacon, Bruce R.Esteban, RafaelBrass, Clifford A.
- [45] PROJECTING THE LONG-TERM CLINICAL IMPACT OF BOCEPREVIR IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 WHO FAILED PRIOR TREATMENT WITH PEGINTERFERON/RIBAVIRINJOURNAL OF HEPATOLOGY, 2011, 54 : S164 - S164Chhatwal, J.Ferrante, S. A.Dasbach, E. J.El Khoury, A.Burroughs, M.Bacon, B.Esteban-Mur, R.Brass, C.
- [46] Rapid normalization of proinflammatory cytokine levels during potent antiviral therapy with sofosbuvir plus ribavirin in patients with genotype 2 and 3 HCV infectionHEPATOLOGY, 2014, 60 : 1059A - 1059AWyles, David L.Stamm, Luisa M.Paulson, MatthewSong, QinghuaBrainard, Diana M.Schooley, Robert T.
- [47] Boceprevir (BOC) plus peginterferon Alfa-2b/Ribavirin (PR) in the treatment of HCV genotype-1 (HCV-G1) infected asian patients in the SPRINT-1, SPRINT-2, RESPOND-2 trialsJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 249 - 249Hu, Ke QinBognar, Fernando AlvarezThompson, SethPedicone, LisaWahl, JaniceLim, Seng Gee
- [48] DEEP SEQUENCING ANALYSES IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH SIMEPREVIR PLUS SOFOSBUVIR WITH/WITHOUT RIBAVIRIN IN THE COSMOS STUDYJOURNAL OF HEPATOLOGY, 2015, 62 : S623 - S623Fevery, B.Thys, K.Van Rossem, E.Verbinnen, T.Picchio, G.Aerssens, J.De Meyer, S.Beumont, M.Kurland, D.Lenz, O.
- [49] GENOTYPIC AND PHENOTYPIC CORRELATES OF RESISTANCE IN HCV GENOTYPE 1A AND 1B INFECTED PATIENTS TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRINHEPATOLOGY, 2011, 54 : 794A - 795AOgert, Robert A.McMonagle, PatriciaBlack, StuartCurry, StephanieGuo, ZhuyanLesburg, CharlesChase, RobertGraham, DonaldBarnard, Richard J.Howe, John A.Hazuda, DariaHowe, Anita Y.
- [50] EFFECT OF TIME TO RESPONSE ON VIRAL BREAKTHROUGH AND RELAPSE RATES IN PATIENTS INFECTED WITH HCV GENOTYPE 1 AND TREATED WITH PEGINTERFERON ALFA-2A PLUS RIBAVIRINHEPATOLOGY, 2008, 48 (04) : 862A - 862AShiffman, Mitchell L.Hamzeh, Fayez M.Chung, Raymond T.